PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Alcoholic extract of Lysimachia vulgaris var. davurica ameliorated liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced NASH [PMID:33494735].
Methanol extract of Lysimachia vulgaris var. davurica decreased fecal pellet output in restraint stress- or 5-hydroxytryptamine (5-HT)-induced IBS mouse models [PMID:38611770].
A combination of compounds including Lythrum salicaria extract alleviated C. jejuni-induced diarrheal symptoms in diseased mice [PMID:37896170].
Yellow loosestrife extracts demonstrated antibacterial activity against 10 different pathogenic bacteria in vitro [PMID:28573234].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33494735 (2021) — Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis. · BMC complementary medicine and therapies
- 2.PMID: 23739890 (2013) — Efficient plant regeneration of yellow loosestrife (Lysimachia vulgaris L.), a medicinal plant. · Acta biologica Hungarica
- 3.PMID: 1144214 (1975) — Flavonoids in the herb of yellow loosestrife (Lysimachia vulgaris L.). · Polish journal of pharmacology and pharmacy
- 4.PMID: 28573234 (2017) — EVALUATION OF ANTIBACTERIAL, ANTITUMOR, ANTIOXIDANT ACTIVITIES AND PHENOLIC CONSTITUENTS OF FIELD-GROWN AND IN VITRO-GROWN LYSIMACHIA VULGARIS L. · African journal of traditional, complementary, and alternative medicines : AJTCAM
- 5.PMID: 24571303